Bajaj Consumer Care is an operating-leverage thesis in a mature, high-penetration hair-oil category. Almond Drops Hair Oil is roughly 80% of revenue, and the company is trying to turn a wholesale-heavy, under-distributed brand into a direct-distribution FMCG franchise while building a second growth portfolio. The Q2 FY27 result showed the operating leverage is real but not yet self-sustaining: revenue grew 27% to INR333 crore, EBITDA was INR83 crore at a 25% margin, and PAT was INR70 crore at 21%. H1 FY27 revenue grew 28% to INR674 crore, H1 EBITDA rose 85% to INR167 crore, and H1 PAT rose 35% to INR141 crore.
The business economics are not a pure category-growth story. ADHO delivered double-digit unit volume growth in Q2 FY27 across pack groups and channels, led by small and medium-sized packs. ASP spend rose 7% year-on-year in Q2 and 18% in H1. Gross margin was 59.9% in Q2 and 60.8% in H1, down from 61.8% in Q1 and 63% in Q4 FY26. Fixed-cost and employee-cost savings allowed the EBITDA margin to reach 25% despite that gross-margin compression. That is the operating leverage: a high-gross-margin brand with a fixed-cost base can protect absolute EBITDA if revenue grows fast enough and costs are held.
The earnings path now depends on three linked variables. First, revenue: management expects high-teens growth for FY27 and aspires to double-digit growth over the long term. It gave no FY28 number. H1 grew 28%, so the high-teens FY27 guide implies a sharp H2 moderation as the base laps. Analyst inference: the full-year guide is achievable only if ADHO volume holds in double digits and the growth portfolio contributes more than it did in FY26.
Second, gross margin. Management is taking a roughly 5% consumer-price increase in Q3 FY27, split roughly equally between a 2-3% frontal increase and a similar ml-age reduction. It declined to guide gross margin, saying the cost basket is at the highest possible level, fresh purchases are small and inventory is lean. It also said it could not tell whether the pricing action would lead to margin improvement. Analyst inference: the Q3 action protects revenue per unit but does not prove the gross-margin trough. If edible-oil and packaging costs stay high, EBITDA margin can compress from 25% even with cost savings.
Third, distribution productivity. The first Aarohan programme added over 1 lakh outlets across 13 states, 1,000-plus distribution points and closed 600 van routes. Aarohan 2.0 targets 10% expansion in urban direct reach and more than that in rural over the next six quarters. Management attributes a 200-300 basis point one-time growth delta to Aarohan and says distribution could drive 2-3 percentage points of volume growth. Those are management claims, not independently verified. The economic test is whether the new outlets raise throughput and range execution, not just direct-reach count.
The growth portfolio is the second leg. Management targets growing non-ADHO revenue from INR225 crore in FY26 to around INR500 crores over three years, a 30s CAGR. Q2 FY27 showed strong coconut volume growth across channels without added free volume, substantially improved growth-portfolio profitability, an Amla Oils test in general trade, an upgraded Body Lotion test on e-commerce, and Banjara's adjacent-category packs with lip balm and color shampoo tests in four southern states. Management will report progress annually. Analyst inference: the target is credible only if coconut sustains volume growth and Banjara's moves beyond test marketing; otherwise the portfolio remains sub-scale and ADHO concentration persists.
Capital allocation is conservative. The Banjara's acquisition is complete, but management has not disclosed a new acquisition and said in Q2 FY27 that it is not at any deal stage. The company is funding distribution expansion and brand investment rather than large fixed capex; the Q2 call disclosed no new company-funded capacity project. The guesthouse purchase and the Guwahati third-party manufacturing change are efficiency actions, not a new capex cycle.
Management delivery is mixed but generally credible. The 16-18% EBITDA floor was exceeded, FY26 revenue growth of 21% was delivered, and the 10% direct-coverage target for FY26 was met. The blemishes are the November 2025 margin-stability call that was overtaken by a 500 basis point jump, and the Q1 FY27 statement that no further pricing actions were planned, which was reversed by the Q3 price increase. Those are revisions under cost volatility, not evidence of broken long-term commitments. The INR500 crore growth-portfolio target and the Banjara's integration remain open.
The falsifiers are specific. A fall in ADHO volume growth below double digits after the Q3 price increase would undermine the revenue guide. Gross margin below 59.9% with EBITDA margin below 20% would show operating leverage is not absorbing input inflation. Aarohan 2.0 outlet additions that do not lift throughput would make the distribution spend an empty investment, which management itself said must show up in growth. A growth-portfolio year that leaves the INR500 crore path visibly short would keep the company a single-brand story. A reversal in international, especially Bangladesh, would remove a support. Conversely, if Q3 price actions hold volume, gross margin stabilises, and Aarohan 2.0 outlets become productive, the current 25% EBITDA margin can be a base rather than a peak.
companyname: Bajaj Consumer Care Limited ticker: BAJAJCON sector: FMCG - Hair Oil & Personal Care Bajaj Consumer Care Limited (BCCL) is an Indian FMCG company focused on hair oils and personal care. It is part of the Shishir Bajaj Group and was listed on the NSE and BSE in 2010. The company's flagship brand, Bajaj Almond Drops Hair Oil (ADHO), holds a 63%+ market share in the Light Hair Oil category in India, and the company serves over 6 crore consumers across 30+ countries. The business is b...
Read the full report →none
Q2 FY27 call: management expects high-teens revenue growth for FY27 and aspires to double-digit growth over the long term; it gave no quarterly or FY28 quantitative guidance. For Q3 FY27 it plans a roughly 5% consumer-price increase, split roughly equally between a 2-3% frontal price increase and a similar contribution from ml-age reduction. It did not guide gross margin or EBITDA margin, citing cost volatility.
Guidance maintainedoverdeliver
Get valuation models, detailed research reports, thematic primers, one-pagers, risk analysis, growth triggers, bear case, capex tracker, walk the talk, and more for Bajaj Consumer Care Limited and 4,900+ companies.
5-day free pass. No card required.